Table 2.
HC | CHR-Ra | CHR-NRb | Statistical Analysisc | Post Hoc Analysisd | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
(N = 47) | (N = 17) | (N = 31) | |||||||||
Mean | SD | Mean | SD | Mean | SD | F | P | A vs B | A vs C | B vs C | |
Amplitude (μV) | |||||||||||
F3 | −2.2 | 1.1 | −2.5 | 1.0 | −1.8 | 0.8 | 4.627 | .012* | .955 | .008* | .019* |
Fz | −2.7 | 1.2 | −3.0 | 1.2 | −2.2 | 1.0 | 5.875 | .004** | .814 | .002** | .014* |
F4 | −2.7 | 1.2 | −3.0 | 1.1 | −2.4 | 0.9 | 3.614 | .031* | .793 | .013* | .060 |
FC3 | −1.9 | 1.0 | −2.0 | 0.8 | −1.7 | 0.7 | 2.009 | .140 | .745 | .058 | .189 |
FCz | −2.7 | 1.7 | −2.7 | 1.2 | −2.2 | 0.8 | 6.491 | .002** | .225 | .001** | .067 |
FC4 | −2.6 | 1.2 | −2.5 | 0.9 | −2.3 | 0.9 | 1.200 | .306 | .519 | .125 | .498 |
Latency (ms) | |||||||||||
F3 | 181.9 | 25.9 | 173.0 | 25.0 | 170.7 | 24.3 | 1.464 | .237 | .269 | .101 | .764 |
Fz | 182.5 | 25.1 | 177.3 | 23.6 | 172.9 | 21.9 | 1.904 | .155 | .304 | .055 | .533 |
F4 | 182.4 | 25.5 | 174.8 | 24.2 | 170.9 | 21.3 | 3.694 | .029* | .093 | .009** | .571 |
FC3 | 177.5 | 29.2 | 176.8 | 26.4 | 173.6 | 26.8 | 0.484 | .618 | .656 | .328 | .693 |
FCz | 183.3 | 22.5 | 178.2 | 17.9 | 174.7 | 22.4 | 1.154 | .320 | .450 | .133 | .591 |
FC4 | 175.5 | 23.4 | 175.4 | 24.2 | 162.3 | 15.8 | 4.351 | .016* | .727 | .006** | .044* |
Note: HC, healthy control; CHR, clinical high risk; A, HC; B, CHR-R; C, CHR-NR.
aRemitted at last follow-up point.
bDid not remit at last follow-up point.
cAnalysis of variance with age as covariate.
d P value of post hoc analysis using simple contrast test.
*The mean difference is significant at the .05 level.
**The mean difference is significant at the .005 level.